Skip to main content

Table 2 Patient Clinical Characteristics and Treatment

From: Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden

 

Mean (+/−SE)/no.(%)

P Value

MV

N = 2,546

No MV

N = 19,805

All

N = 22,350

No. of chronic conditions

4.2 (+/−0.06)

4.3 (+/−0.03)

4.3 (+/−0.03)

<.001

Chronic obstructive pulmonary disease

736 (28.9%)

7,800 (39.4%)

8,535 (38.2%)

<.001

Bacterial pneumonia

1,252 (49.2%)

7,352 (37.1%)

8,604 (38.5%)

<.001

Lung cancer

59 (2.3%)

348 (1.8%)

407 (1.8%)

0.380

Cardiovascular conditions

1,229 (48.3%)

8,835 (44.6%)

10,063 (45.0%)

0.137

 Ischemic heart disease

717 (28.2%)

5,622 (28.4%)

6,339 (28.4%)

0.913

 Myocardial infarction

267 (10.5%)

1,078 (5.4%)

1,345 (6.0%)

<.001

 Congestive heart failure

793 (31.1%)

5,427 (27.4%)

6,219 (27.8%)

0.119

 Pulmonary hypertension

19 (0.8%)

65 (0.3%)

84 (0.4%)

0.146

APR-DRG severity of illness

   

<.001

 Minor loss of function

5 (0.2%)

443 (2.2%)

447 (2.0%)

 

 Moderate loss of function

16 (0.6%)

5,042 (25.5%)

5,058 (22.6%)

 

 Major loss of function

341 (13.4%)

10,197 (51.5%)

10,538 (47.1%)

 

 Extreme loss of function

2,184 (85.8%)

4,123 (20.8%)

6,307 (28.2%)